New Year Bumper Sale @ Rs. 1 X
Lamivir SE is an allopathic medicine The correct dosage of Lamivir SE depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Lamivir SE is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Lamivir SE safe for pregnant women?
Pregnant women may experience moderate side effects from Lamivir SE. It is best to stop taking Lamivir SE immediately and inform your doctor if you notice any discomfort.
Is the use of Lamivir SE safe during breastfeeding?
Side effects of Lamivir SE for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Lamivir SE on the Kidneys?
Lamivir SE has very mild side effects on the kidneys.
What is the effect of Lamivir SE on the Liver?
Very few cases of side effects of Lamivir SE on the liver have been reported.
What is the effect of Lamivir SE on the Heart?
You can take Lamivir SE without any fear of damage to the heart.
Lamivir SE should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Lamivir SE unless your doctor advises you to do so -
Is this Lamivir SE habit forming or addictive?
Lamivir SE is not addictive in nature.
Interaction between Food and Lamivir SE
Taking Lamivir SE with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Lamivir SE
Taking Lamivir SE with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Epivir (lamivudine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 807-808
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 96-99
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sustiva® (efavirenz)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 481-483
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 809-810
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zerit® (stavudine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 807